2.2 mg tirzepatide GLP-2 (40mg vials) Tirzepatide Dosage for Weight Loss

Research has characterised Tirzepatides cardiac biology examining GLP-1R-mediated cardiomyocyte PI3K-Akt pro-survival signalling in ischaemia-reperfusion models, endothelial GLP-1R anti-inflammatory and anti-atherosclerotic biology, GIPR-mediated vascular biology, and the cardiovascular consequences of Tirzepatides superior metabolic efficacy relative to GLP-1R monoagonism

[4] Jastreboff, A

The maximum reductions in HbA 1c and bodyweight observed in the current study (18.72 mmol/mol [1.71%] and 8.4 kg, respectively) exceeded those of the above studies, after a shorter treatment duration of only 16 weeks

However, it should only be used upon your doctor's recommendation and after all the risks and benefits are discussed

2.5-10 mg TID